| Apolipoprotein E polymorphism in a Danish population compared to findings in 45 other study populations around the world | Genetic Epidemiology | 1992 | 230 |
| Predictive value of stroke and transient ischemic attack discharge diagnoses in The Danish National Registry of Patients | Journal of Clinical Epidemiology | 2002 | 140 |
| Intake of fruit and vegetables and the risk of ischemic stroke in a cohort of Danish men and women | American Journal of Clinical Nutrition | 2003 | 139 |
| Detection of the apoB-3500 mutation (glutamine for arginine) by gene amplification and cleavage with MspI | Journal of Lipid Research | 1991 | 79 |
| Flecainide acetate in atrial flutter and fibrillation. The arrhythmogenic effects | European Heart Journal | 1990 | 45 |
| Generation of analytic plasma lipoprotein profiles using two prepacked superose 6B columns | Clinica Chimica Acta | 1992 | 40 |
| Identification of recurrent and novel mutations in the LDL receptor gene in Spanish patients with familial hypercholesterolemia | Human Mutation | 1998 | 25 |
| Differences in apolipoprotein (a) polymorphism in west Greenland Eskimos and Caucasian Danes | Human Genetics | 1992 | 24 |
| Biological variation of International Normalized Ratio for prothrombin times, and consequences in monitoring oral anticoagulant therapy: computer simulation of serial measurements with goal-setting for analytical quality | Clinical Chemistry | 1997 | 21 |
| Chlamydia pneumoniae seropositivity and risk of ischemic stroke: a nested case-control study | European Journal of Epidemiology | 2005 | 13 |
| Platelet-derived growth factor release and antiplatelet treatment with low-dose acetylsalicylic acid | Angiology | 1993 | 13 |
| Pharmacokinetics of xamoterol after intravenous and oral administration to patients with chronic heart failure | European Journal of Clinical Pharmacology | 1988 | 10 |
| Influence of nifedipine on coronary haemodynamics and myocardial metabolism in coronary artery disease | European Heart Journal | 1985 | 10 |
| A PvuII polymorphism of the low density lipoprotein receptor gene is not associated with plasma concentrations of low density lipoproteins including LP(a) | Human Genetics | 1993 | 9 |
| Beneficial effect of a low-fat low-calorie diet on myocardial energy metabolism in patients with angina pectoris | Lancet, The | 1984 | 9 |
| Two novel mutations in the LDL receptor gene: common causes of familial hypercholesterolemia in a Spanish population | Clinical Genetics | 1996 | 8 |
| Identification of a novel mutation in exon 13 of the LDL receptor gene causing familial hypercholesterolemia in two Spanish families | Biochimica Et Biophysica Acta - Molecular Basis of Disease | 1996 | 7 |
| An alanine29-serine variant in exon 2 of the low density lipoprotein receptor gene: no association with hypercholesterolemia | Clinical Genetics | 1994 | 6 |
| An Iranian-Armenian LDLR frameshift mutation causing familial hypercholesterolemia | Clinical Genetics | 1996 | 6 |
| A comparison of lifestyle, genetic, bioclinical and biochemical variables of offspring with and without family histories of premature coronary heart disease: the experience of the European Atherosclerosis Research Studies | European Journal of Cardiovascular Prevention and Rehabilitation | 1999 | 6 |
| Ischaemic left ventricular failure: evidence of sustained benefit after 18 months' treatment with xamoterol | Heart | 1990 | 5 |
| Effects of diabetes, insulin treatment, and osmolality on contractility of isolated rat resistance arteries | Basic and Clinical Pharmacology and Toxicology | 1995 | 4 |
| Complexity of molecular genetics of dyslipidemia in a family highly susceptible to ischemic heart disease | Clinical Genetics | 1995 | 3 |
| Comparison of the effects of xamoterol, atenolol and propranolol on breathlessness, fatigue and plasma electrolytes during exercise in healthy volunteers | European Journal of Clinical Pharmacology | 1991 | 3 |
| Long-term efficacy of xamoterol (a beta 1-adrenoceptor partial agonist) in patients with mild to moderate heart failure | British Journal of Clinical Pharmacology | 1989 | 2 |
